DiaMedica Therapeutics
DMAC
DMAC
32 hedge funds and large institutions have $15.1M invested in DiaMedica Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
3.26% more ownership
Funds ownership: 9.7% → 12.96% (+3.3%)
Holders
32
Holding in Top 10
1
Calls
$127K
Puts
$1K
Top Buyers
| 1 | +$1.4M | |
| 2 | +$1.27M | |
| 3 | +$1.17M | |
| 4 |
First Manhattan
New York
|
+$539K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.1K |
Top Sellers
| 1 | -$151K | |
| 2 | -$148K | |
| 3 | -$99K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$37.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.12K |